Deborah M. Messemer - Net Worth and Insider Trading

Deborah M. Messemer Net Worth

The estimated net worth of Deborah M. Messemer is at least $3 Million dollars as of 2024-12-28. Deborah M. Messemer is the Director of PayPal Holdings Inc and owns about 13,976 shares of PayPal Holdings Inc (PYPL) stock worth over $1 Million. Deborah M. Messemer is the Director of TPG Inc and owns about 17,536 shares of TPG Inc (TPG) stock worth over $1 Million. Deborah M. Messemer is also the Director of Allogene Therapeutics Inc and owns about 157,629 shares of Allogene Therapeutics Inc (ALLO) stock worth over $345,208. Details can be seen in Deborah M. Messemer's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Deborah M. Messemer has not made any transactions after 2024-12-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Deborah M. Messemer

To

Deborah M. Messemer Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Deborah M. Messemer owns 3 companies in total, including Allogene Therapeutics Inc (ALLO) , PayPal Holdings Inc (PYPL) , and TPG Inc (TPG) .

Click here to see the complete history of Deborah M. Messemer’s form 4 insider trades.

Insider Ownership Summary of Deborah M. Messemer

Ticker Comapny Transaction Date Type of Owner
ALLO Allogene Therapeutics Inc 2024-12-09 director
PYPL PayPal Holdings Inc 2024-05-24 director
TPG TPG Inc 2024-07-17 director

Deborah M. Messemer Latest Holdings Summary

Deborah M. Messemer currently owns a total of 3 stocks. Among these stocks, Deborah M. Messemer owns 13,976 shares of PayPal Holdings Inc (PYPL) as of May 24, 2024, with a value of $1 Million and a weighting of 45.28%. Deborah M. Messemer owns 17,536 shares of TPG Inc (TPG) as of July 17, 2024, with a value of $1 Million and a weighting of 41.85%. Deborah M. Messemer also owns 157,629 shares of Allogene Therapeutics Inc (ALLO) as of December 9, 2024, with a value of $345,208 and a weighting of 12.87%.

Latest Holdings of Deborah M. Messemer

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PYPL PayPal Holdings Inc 2024-05-24 13,976 86.86 1,213,955
TPG TPG Inc 2024-07-17 17,536 63.99 1,122,129
ALLO Allogene Therapeutics Inc 2024-12-09 157,629 2.19 345,208

Holding Weightings of Deborah M. Messemer


Deborah M. Messemer Form 4 Trading Tracker

According to the SEC Form 4 filings, Deborah M. Messemer has made a total of 1 transactions in PayPal Holdings Inc (PYPL) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in PayPal Holdings Inc is the sale of 4,422 shares on May 24, 2024, which brought Deborah M. Messemer around $272,616.

According to the SEC Form 4 filings, Deborah M. Messemer has made a total of 2 transactions in TPG Inc (TPG) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in TPG Inc is the sale of 4,089 shares on July 17, 2024, which brought Deborah M. Messemer around $190,343.

According to the SEC Form 4 filings, Deborah M. Messemer has made a total of 3 transactions in Allogene Therapeutics Inc (ALLO) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Allogene Therapeutics Inc is the sale of 9,136 shares on December 9, 2024, which brought Deborah M. Messemer around $19,917.

Insider Trading History of Deborah M. Messemer

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Deborah M. Messemer Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Deborah M. Messemer Ownership Network

Ownership Network List of Deborah M. Messemer

No Data

Ownership Network Relation of Deborah M. Messemer

Insider Network Chart

Deborah M. Messemer Owned Company Details

What does Allogene Therapeutics Inc do?

Who are the key executives at Allogene Therapeutics Inc?

Deborah M. Messemer is the director of Allogene Therapeutics Inc. Other key executives at Allogene Therapeutics Inc include director & 10 percent owner Arie Belldegrun , CHIEF FINANCIAL OFFICER Geoffrey M. Parker , and GENERAL COUNSEL Earl Martin Douglas .

Allogene Therapeutics Inc (ALLO) Insider Trades Summary

Over the past 18 months, Deborah M. Messemer made 3 insider transaction in Allogene Therapeutics Inc (ALLO) with a net sale of 46,417. Other recent insider transactions involving Allogene Therapeutics Inc (ALLO) include a net sale of 20,421 shares made by Franz B Humer , a net purchase of 1,724,137 shares made by Arie Belldegrun , and a net sale of 10,000 shares made by Stephen Mayo .

In summary, during the past 3 months, insiders sold 18,357 shares of Allogene Therapeutics Inc (ALLO) in total and bought 0 shares, with a net sale of 18,357 shares. During the past 18 months, 76,838 shares of Allogene Therapeutics Inc (ALLO) were sold and 1,724,327 shares were bought by its insiders, resulting in a net purchase of 1,647,489 shares.

Allogene Therapeutics Inc (ALLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Allogene Therapeutics Inc Insider Transactions

No Available Data

Deborah M. Messemer Mailing Address

Above is the net worth, insider trading, and ownership report for Deborah M. Messemer. You might contact Deborah M. Messemer via mailing address: C/o Allogene Therapeutics, Inc., 210 East Grand Avenue, South San Francisco Ca 94080.

Discussions on Deborah M. Messemer

No discussions yet.